0001209726-11-000002.txt : 20111017 0001209726-11-000002.hdr.sgml : 20111017 20111017123436 ACCESSION NUMBER: 0001209726-11-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111014 FILED AS OF DATE: 20111017 DATE AS OF CHANGE: 20111017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEPHALON INC CENTRAL INDEX KEY: 0000873364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232484489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 BUSINESS PHONE: 6103440200 MAIL ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EGAN WILLIAM P CENTRAL INDEX KEY: 0001066140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19119 FILM NUMBER: 111143326 MAIL ADDRESS: STREET 1: 200 CLARENDON ST STREET 2: 51ST FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2011-10-14 1 0000873364 CEPHALON INC CEPH 0001066140 EGAN WILLIAM P 200 CLARENDON ST 51ST FLOOR BOSTON MA 02116 1 0 0 0 Common Stock 2011-10-14 4 D 0 21661 D 0 I By Trust Non-Qualified Stock Option 58.67 2011-10-14 4 D 0 10000 D 2006-05-15 2012-05-15 Common Stock 10000 0 D Non-Qualified Stock Option 45.23 2011-10-14 4 D 0 10000 D 2007-05-29 2013-05-29 Common Stock 10000 0 D Non-Qualified Stock Option 54.5 2011-10-14 4 D 0 10000 D 2008-05-13 2014-05-13 Common Stock 10000 0 D Non-Qualified Stock Option 44.09 2011-10-14 4 D 0 10000 D 2009-05-18 2015-05-18 Common Stock 10000 0 D Non-Qualified Stock Option 60.08 2011-10-14 4 D 0 10000 D 2010-05-17 2016-05-17 Common Stock 10000 0 D Non-Qualified Stock Option 79.99 2011-10-14 4 D 0 10000 D 2011-05-17 2017-05-17 Common Stock 10000 0 D Non-Qualified Stock Option 67.66 2011-10-14 4 D 0 10000 D 2012-05-22 2018-05-22 Common Stock 10000 0 D Non-Qualified Stock Option 66.55 2011-10-14 4 D 0 10000 D 2013-05-12 2019-05-12 Common Stock 10000 0 D Non-Qualified Stock Option 59.18 2011-10-14 4 D 0 15000 D 2014-05-20 2020-05-20 Common Stock 15000 0 D Non-Qualified Stock Option 79.85 2011-10-14 4 D 0 15000 D 2015-05-10 2021-05-10 Common Stock 15000 0 D Common Stock was converted pursuant to the Agreement and Plan of Merger, dated as of May 1, 2011, among Teva Pharmaceutical Industries Ltd., Copper Acquisition Corp. and Cephalon, Inc. (the "Merger Agreement") into the right to receive the Merger Consideration (as defined in the Merger Agreement) of $81.50 per share in cash. Options were canceled at the Effective Time of the Merger pursuant to the terms of the Merger Agreement in exchange for a cash payment for each share subject to the option equal to the difference between the Merger Consideration of $81.50 per share and the exercise price of the option. Reflects four-year anniversary from date of grant. Options vest 25% on each anniversary of grant and expire ten years from date of grant. Carolyn S. Iosca, Attorney-in-Fact for William P. Egan 2011-10-17